VitroScan, developing tests to predict treatment outcome for
cancer patients, has closed a round of seed funding for €800.000. Lead investor
Libertatis Ergo Holding B.V. (LEH) will be welcomed as new board member. Pieter
Geelen, TomTom founder and philanthropist, and co-founder of VitroScan also
provides a major part of the funds in this round. VitroScan will use the proceeds
to deliver Proof of Concept for application of its unique technology for
treatment response prediction for cancer patients.
Suboptimal therapy responses for patients, unnecessary side
effects, and high failure rates of clinical trials with cancer drugs, cause a
high burden on the health care system. This emphasises the need for better
selection of treatment for the individual patient, and more efficient drug
VitroScan’s unique technology platform combines automated 3D
cell culture with high content 3D imaging and analysis in a robust platform
that provides scalability without compromising precision of drug response
analysis. A clinical trial program has been initiated with leading cancer
hospitals in The Netherlands to establish the value of the technology for drug
response prediction in selected cancers.
Quote LEH: “Leiden University is very excited to support VitroScan’s ambition to develop solutions and optimize treatment for cancer patients, to build on the strong technical foundation between VitroScan and Leiden University and to support entrepreneurship on the Leiden Bio Science Park.” Quote Willemijn Vader, Managing Director VitroScan: “We are excited to welcome LEH in the board of VitroScan. LEH’s expertise will facilitate collaborations with the University Medical Centers, like LUMC and the Leiden Bio Science Park Community, and will be valuable to execute our strategy and achieve our goals.”
HollandBIO is de belangenvereniging van biotech bedrijven in Nederland. Samen werken we aan ons toekomstideaal: een maatschappij waarin biotechnologie maximaal bijdraagt aan gezondheid, duurzaamheid en economische groei.
Laan van Nieuw Oost-Indië 131-133
2593 BM Den Haag
Laan van Nieuw Oost-Indië 131 E
2593 BM Den Haag